MYC and Miyoshi myopathy: MYC signaling (MGUS, p < 0.05) [20], cell cycle-related E2F targets (SMM, p < 0.05) and interferon alpha (IFNα) response (SMM, p < 0.05) pathways were enriched early and increased with MM progression (Fig 2E).